Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
This study has been completed.
Study NCT00107107   Information provided by Amylin Pharmaceuticals, LLC.

First Received on April 5, 2005.   Last Updated on February 8, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 1
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
pramlintide acetate
Additional drug interventions recognized in this trial
Islet Amyloid Polypeptide
Pramlintide
More general drug interventions related to this trial
Anti-Obesity Agents
Appetite Depressants
Central Nervous System Agents
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Amylin Pharmaceuticals, LLC.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services